Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HERON THERAPEUTICS, INC. /DE/ | Director | Stock Option (Right to Buy) | 83.7K | $149K | $1.78 | Jan 19, 2024 | Direct |
HERON THERAPEUTICS, INC. /DE/ | Director | Common Stock | 65.8K | $142K | $2.15 | Jan 19, 2024 | Direct |
LA JOLLA PHARMACEUTICAL CO | Director | Common Stock | 0 | $6.23 | Aug 22, 2022 | Direct | |
LA JOLLA PHARMACEUTICAL CO | Director | Stock Option (Right to Buy) | 0 | Aug 22, 2022 | Direct | ||
Mirati Therapeutics, Inc. | Director | Common Stock | 0 | $59.02 | Jan 23, 2024 | Direct | |
Mirati Therapeutics, Inc. | Director | Option to Purchase Common Stock | 0 | Jan 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MRTX | Mirati Therapeutics, Inc. | Jan 23, 2024 | 8 | $0 | 4 | Jan 23, 2024 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Jan 19, 2024 | 2 | $0 | 4 | Jan 19, 2024 | Director |
MRTX | Mirati Therapeutics, Inc. | Dec 29, 2023 | 1 | $400K | 4 | Jan 3, 2024 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 20, 2023 | 2 | $0 | 4 | Jan 24, 2023 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Dec 16, 2022 | 2 | $0 | 4 | Dec 20, 2022 | Director |
LJPC | LA JOLLA PHARMACEUTICAL CO | Aug 22, 2022 | 11 | -$74.8K | 4 | Aug 24, 2022 | Director |
LJPC | LA JOLLA PHARMACEUTICAL CO | Jul 8, 2022 | 2 | $47.2K | 4 | Jul 12, 2022 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 18, 2022 | Director |
LJPC | LA JOLLA PHARMACEUTICAL CO | Jan 12, 2022 | 1 | $0 | 4 | Jan 14, 2022 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Dec 21, 2021 | 3 | -$2.43K | 4 | Dec 23, 2021 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Sep 21, 2021 | 1 | -$3.07K | 4 | Sep 23, 2021 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Jun 21, 2021 | 1 | -$3.8K | 4 | Jun 22, 2021 | Director |